Beyond CAR T cells: exploring alternative cell sources for CAR-like cellular therapies
Chimeric antigen receptor (CAR)-T cell therapy has led to remarkable clinical outcomes in the treatment of hematological malignancies. However, challenges remain, such as limited infiltration into solid tumors, inadequate persistence, systemic toxicities, and manufacturing insufficiencies. The use o...
Shranjeno v:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Revisão |
| Jezik: | angleščina |
| Izdano: |
2024
|
| Online dostop: | https://doi.org/10.1515/hsz-2023-0317 https://www.degruyter.com/document/doi/10.1515/hsz-2023-0317/pdf |
| Oznake: |
Označite
Brez oznak, prvi označite!
|